Sermorelin

This classification denotes a growth hormone-releasing hormone analogue with the molecular formula C149H246N44O42S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 89243S03TE, chemically known as somatoliberin (human pancreatic islet), 29-l-argininamide-30-de-l-glutamine-31-de-l-glutamine-32-deglycine-33-de-l-glutamic acid-34-de-l-serine-35-de-l-asparagine-36-de-l-glutamine-37-de-l-glutamic acid-38-de-l-arginine-39-deglycine-40-de-l-alanine-41-de-l-arginine-42-de-l-alanine-43-de-l-argininyl-44-de-l-leucinamide but generally known as sermorelin, which bears US NIH Compound Identifier 16129620. European Medicines Agency schedules Sermorelin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10496MIG. World Health Organization schedules sermorelin in its Anatomical Therapeutic Chemical (ATC) Classification. SERMORELIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule sermorelin under HS 29371900 and SITC 54154. As of Q4 2014, SERMORELIN remains the US FDA Preferred Term for this commodity. Sermorelin bears US NLM identifiers UMLS ID C0142046 and NCI Concept Code C62088. SMILES: S(CCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(N)CC1CCC(O)CC1)C)CC(=O)O)C)C(CC)C)CC1CCCCC.